These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2550018)

  • 1. Seroprevalence of human parvovirus B19 infection in Sao Tomé and Principe, Malawi and Mascarene Islands.
    Schwarz TF; Gürtler LG; Zoulek G; Deinhardt F; Roggendorf M
    Zentralbl Bakteriol; 1989 Jul; 271(2):231-6. PubMed ID: 2550018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Parvovirus B19 infections in Germany 1987-1988].
    Schwarz TF; Jäger G; Schlipköter UA; Wiersbitzky S; Tiller FW; Hottenträger B; Deinhardt F; Roggendorf M
    Offentl Gesundheitswes; 1990 Feb; 52(2):53-7. PubMed ID: 2158028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of human parvovirus B19 in a suburban population in São Paulo, Brazil.
    Huatuco EM; Durigon EL; Lebrun FL; Passos SD; Gazeta RE; Azevedo Neto RS; Massad E
    Rev Saude Publica; 2008 Jun; 42(3):443-9. PubMed ID: 18425294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroprevalence of human parvovirus B 19 antibodies (Sticker's disease/erythema infectiosum) in the DRG population].
    Wiersbitzky S; Schwarz TF; Bruns R; Jäger G; Bittner S; Weidemann H; Deinhardt F; Hottenträger B; Abel E; Ladstätter L
    Kinderarztl Prax; 1990 Apr; 58(4):185-9. PubMed ID: 2164118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human parvovirus B19: ELISA and immunoblot assays.
    Schwarz TF; Roggendorf M; Deinhardt F
    J Virol Methods; 1988 Jun; 20(2):155-68. PubMed ID: 2843558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunosorbent assay for IgG and IgM antibodies against human parvovirus B19: use of monoclonal antibodies and viral antigen propagated in vitro.
    Yaegashi N; Shiraishi H; Tada K; Yajima A; Sugamura K
    J Virol Methods; 1989 Nov; 26(2):171-81. PubMed ID: 2559100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.
    Anderson LJ; Tsou C; Parker RA; Chorba TL; Wulff H; Tattersall P; Mortimer PP
    J Clin Microbiol; 1986 Oct; 24(4):522-6. PubMed ID: 3021807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
    Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
    Türk Dağı H; Ozdemir M; Baykan M; Baysal B
    Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus B19 infection in Hong Kong.
    Lim WL; Wong KF; Lau CS
    J Infect; 1997 Nov; 35(3):247-9. PubMed ID: 9459396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil.
    de Freitas RB; Wong D; Boswell F; de Miranda MF; Linhares AC; Shirley J; Desselberger U
    J Med Virol; 1990 Dec; 32(4):203-8. PubMed ID: 1964474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of parvovirus B19 infection. Seroepidemiologic studies].
    Schwarz TF; Roggendorf M; Deinhardt F
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1526-31. PubMed ID: 2820687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil.
    Nascimento JP; Buckley MM; Brown KE; Cohen BJ
    Rev Inst Med Trop Sao Paulo; 1990; 32(1):41-5. PubMed ID: 2175446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvovirus B19 antibodies in immunocompromized children in Thailand.
    Suandork P; Theamboonlers A; Likitnukul S; Hirsch P; Poovorawan Y
    Asian Pac J Allergy Immunol; 2000 Sep; 18(3):161-4. PubMed ID: 11270472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies.
    Schwarz TF; Modrow S; Hottenträger B; Höflacher B; Jäger G; Scharti W; Sumazakl R; Wolf H; Middeldorp J; Roggendorf M
    J Clin Microbiol; 1991 Mar; 29(3):431-5. PubMed ID: 1645365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
    Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
    J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to B19 parvovirus and an antibody defect in persistent viral infection.
    Kurtzman GJ; Cohen BJ; Field AM; Oseas R; Blaese RM; Young NS
    J Clin Invest; 1989 Oct; 84(4):1114-23. PubMed ID: 2551923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
    González M; Hassanhi M; Rivera S; Bracho MP
    Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology of human parvovirus B19 in Taiwan.
    Lin KH; You SL; Chen CJ; Wang CF; Yang CS; Yamazaki S
    J Med Virol; 1999 Feb; 57(2):169-73. PubMed ID: 9892403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of active parvovirus B19 infection in HIV-infected patients.
    Raguin G; Leruez-Ville M; Gregoire V; Deplanche M; Leport C; Morinet F; Vilde JL
    Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):760-2. PubMed ID: 9405950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.